Nightingale Health Oyj (NHLTY)

Market Cap	67.27M -59.8%
Revenue (ttm)	6.29M +17.2%
Net Income	-21.10M
EPS	-0.35
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	1.150
Previous Close	1.150
Day's Range	1.150 - 1.150
52-Week Range	0.916 - 2.550
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 16, 2026

About Nightingale Health Oyj

Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company’s Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare...

• Industry: Medical Laboratories
• Founded: 2002
• Employees: 101
• Stock Exchange: OTCMKTS
• Ticker Symbol: NHLTY

Financial Performance

In fiscal year 2026, Nightingale Health Oyj's revenue was 5.50 million, an increase of 17.24% compared to the previous year's 4.69 million. Losses were -18.47 million, 0.06% more than in 2025.

Financial numbers in EUR

Data Sources: S&P Global Market Intelligence and Alpha Vantage

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Alpha Vantage.

Last checked:

Sep 25, 2026

Data Sources Report a data error